OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
Siming Qu, Jin Li, Hanfei Huang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Siming Qu, Jin Li, Hanfei Huang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 145
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 145
ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression
Yu You, Diguang Wen, Lu Zeng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5001-5018
Open Access | Times Cited: 75
Yu You, Diguang Wen, Lu Zeng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5001-5018
Open Access | Times Cited: 75
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma
Yuhan Chen, Peitao Zhou, Yixun Deng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 31
Yuhan Chen, Peitao Zhou, Yixun Deng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 31
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
Yuhua Hu, Feng Shen, Xi Yang, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Yuhua Hu, Feng Shen, Xi Yang, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 30
Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p
Shenqi Han, Lin Xue, Yi Wei, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 19
Shenqi Han, Lin Xue, Yi Wei, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 19
RNA m6A methylation regulators in liver cancer
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think
April M. Weissmiller, Stephen W. Fesik, William P. Tansey
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 274-274
Open Access | Times Cited: 8
April M. Weissmiller, Stephen W. Fesik, William P. Tansey
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 274-274
Open Access | Times Cited: 8
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011917-e1011917
Open Access | Times Cited: 7
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011917-e1011917
Open Access | Times Cited: 7
Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 15
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 15
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
The role of demethylase AlkB homologs in cancer
Qiao Li, Qingsan Zhu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Qiao Li, Qingsan Zhu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway
Qinyan Yang, Yuxin Liang, Ying Shi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15499-15510
Closed Access | Times Cited: 12
Qinyan Yang, Yuxin Liang, Ying Shi, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15499-15510
Closed Access | Times Cited: 12
New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview
Evelina Charidemou, Costas Koufaris, Maria Louca, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 6, pp. 1594-1605
Open Access | Times Cited: 10
Evelina Charidemou, Costas Koufaris, Maria Louca, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 6, pp. 1594-1605
Open Access | Times Cited: 10
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Hepatitis B Virus Promotes Angiogenesis in Hepatocellular Carcinoma by Increasing m6A Modification of VEGFA mRNA via IGF2BP3
Xiaoxin Xu, Yi Zhang, Shuxiang Wu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 5
Closed Access
Xiaoxin Xu, Yi Zhang, Shuxiang Wu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 5
Closed Access
RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis
Wenbo Ma, Tong Wu
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1190-C1205
Open Access | Times Cited: 15
Wenbo Ma, Tong Wu
AJP Cell Physiology (2022) Vol. 323, Iss. 4, pp. C1190-C1205
Open Access | Times Cited: 15
